Insider Trading activities of Bind Therapeutics, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bind Therapeutics, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bind Therapeutics, Inc since year 2005. Table 2 shows the detailed insider transactions of Bind Therapeutics, Inc since 2005. The reporting company's ticker symbol is BIND. The reporting company's CIK number is 1385228.
The total value of stock buying since 2005 is $2,790,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $41,800.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bind Therapeutics, Inc (BIND).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-08 0 $0 0 $0 95,000 $41,800
2013-09 186,000 $2,790,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Bind Therapeutics, Inc insiders (BIND)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-08-29 Rowinsky Eric K (Director) Option Ex 15,000 .44 6,600
2016-08-29 Hutt Peter Barton (Director) Option Ex 15,000 .44 6,600
2016-08-26 Tzianabos Arthur (Director) Option Ex 15,000 .44 6,600
2016-08-26 Rowland Charles A Jr (Director) Option Ex 15,000 .44 6,600
2016-08-26 Langer Robert (Director) Option Ex 15,000 .44 6,600
2016-08-26 Lynch Daniel (Director) Option Ex 20,000 .44 8,800
2013-09-25 Rusnano (10% Owner) Buy 120,000 15.00 1,800,000
2013-09-25 Flint Jonathan A (10% Owner) Buy 26,000 15.00 390,000
2013-09-25 Kania Edwin M Jr (10% Owner) Buy 20,000 15.00 300,000
2013-09-25 Afeyan Noubar (Director) Buy 20,000 15.00 300,000

Insider trading activities including stock purchases, stock sales, and option exercises of BIND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bind Therapeutics, Inc (symbol BIND, CIK number 1385228) see the Securities and Exchange Commission (SEC) website.